Floatz logo

ct125a cells

Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma

Huazhong University of Science and TechnologyCell therapyEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

36 Active assets in the Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
City of Hope Medical Center
Phase 2BB
ETOPOSIDE
Alliance for Clinical Trials in Oncology
Phase 4BB
DEXAMETHASONE
Zhengzhou University
Phase 4BB
PREDNISONE TABLETS
City of Hope Medical Center
Phase 2BB
FILGRASTIM
City of Hope Medical Center
Phase 2BB

View all 50 →

Same molecule, other indications

ct125a cells is also rated in:

hematopoietic and lymphoid system neoplasmDormant
C
Indicative ·
39 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
C
Indicative ·
39 / 100
View asset →
mantle cell lymphomaDormant
C
Indicative ·
38 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →